Skip to main content
Home
Issues
2024
November 2024 Vol 17, Payers' Guide to FDA Updates
2023
December 2023 Vol 16, Payers' Guide to FDA Updates
September 2023 Vol 16, Payers' Guide to FDA Updates
June 2023 - Vol 16 No 1
Issue Archive
Topics
Conference Correspondent
ESMO 2024 - Small Cell Lung Cancer
EHA 2024 – Wrap-Up: Myelodysplastic Syndrome
ASCO 2024 – Wrap-Up: Myelodysplastic Syndrome
Multimedia
Videos
Interview with the Innovators
Editorial Board
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Process
Advertising Policy
Subscribe
Home
Issues
2024
November 2024 Vol 17, Payers' Guide to FDA Updates
2023
December 2023 Vol 16, Payers' Guide to FDA Updates
September 2023 Vol 16, Payers' Guide to FDA Updates
June 2023 - Vol 16 No 1
Issue Archive
Topics
Conference Correspondent
ESMO 2024 - Small Cell Lung Cancer
EHA 2024 – Wrap-Up: Myelodysplastic Syndrome
ASCO 2024 – Wrap-Up: Myelodysplastic Syndrome
Multimedia
Videos
Interview with the Innovators
Editorial Board
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Process
Advertising Policy
Case Reports
Online Only
Case Reports
Rapid Onset of Fatal Tumor Lysis Syndrome in a Patient With Acute Myeloid Leukemia Receiving Azacitidine and Venetoclax Without a Ramp-Up Schedule: A Case Report
Zachary Schonrock, BA; Ming Hua Ma, BS; Saaiqa Maredia Momin, PharmD; Keith D. Eaton, MD; Simran Ghuman, PharmD
Read More
Online Only
Case Reports
Pacritinib Therapy in a Patient With End-Stage Renal Disease in the Setting of Cytopenic Myelofibrosis
Alexandra Roach, MD; Hayley Heers, PharmD, BCPS, BCOP; Vishangi Dave, MD; Naveen Pemmaraju, MD; Matthew Ulrickson, MD
Read More
Results 1 - 2 of 2